In Conversation

“ Strong science matters, but intellectual property, execution, and strategy decide who ultimately wins ”

“ Population ageing is a formidable challenge, but the P4 framework – preventive, predictive, personalised, participatory – gives us a viable path forward ”

“ The more clinical trials we run locally, the more opportunities we have to introduce innovation earlier ”

“ Taiwan is strategically important for supporting future launches and our 2030 vision ”

“ If you address each of the scientific limitations directly, mRNA cancer vaccines can become a viable therapeutic class ”

“ Taiwan possesses leading-edge capabilities in semiconductors, AI manufacturing, and substantial healthcare data from universal coverage ”

“ We are not trying to be loud. We are focused on being reliable ”

“ Taiwan’s appeal lies in meeting global standards – in quality, work ethic, intellectual property, confidentiality, and legal frameworks – and this enables international customers to trust… ”

“ Asia’s growing importance in clinical research is now unmistakable ”

“ We develop innovation in Taiwan, positioning our nation as a biotechnology innovation hub, whilst targeting global markets ”

“ Talent is the single most critical factor behind the success of Taiwan, Hong Kong and Macao ”

“ Our ambition is not short-term success but to build a sustainable innovation platform across medical aesthetics and metabolic diseases ”